{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:26:28Z","timestamp":1791588388339,"version":"4.3.4"},"reference-count":58,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2006,11,6]],"date-time":"2006-11-06T00:00:00Z","timestamp":1162771200000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2006,11]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> The history of von Willebrand's disease (VWD) is fascinating because it demonstrates how good clinical observations, genetic studies and biochemical skills can improve basic understanding of a disease and its management. The continuous efforts of scientists and clinicians during the last 80\u2003years have significantly improved the knowledge of von Willebrand factor (VWF) structure and function and the management of VWD. Diagnosis of phenotype and genotype is now available in many countries and treatment is becoming more specific according to the VWD type. Any therapeutic agents must correct the dual defect of haemostasis, i.e. the abnormal platelet adhesion due to reduced and\/or dysfunctional and low levels of factor VIII (FVIII) associated with VWF defects. Desmopressin (DDAVP) is the treatment of choice for type 1 VWD because it induces release of VWF from cellular compartments. Plasma virally inactivated VWF concentrates containing FVIII are effective and safe in patients unresponsive to DDAVP. There are advanced plans to develop a recombinant VWF but this product will require the concomitant administration of FVIII for the control of acute bleeds. Basic research studies on cellular biology, biochemistry and immunology have confirmed the role of VWF as a crucial participant in both haemostasis and thrombosis as its main biological activity is to support platelet adhesion\u2013aggregation in the circulation. Retrospective and prospective clinical research studies, including bleeding history and laboratory markers for diagnosis as well as the use of DDAVP and VWF concentrates to manage or prevent bleeds in patients with VWD have been essential to provide general guidelines for VWD management. The large number of publications quoting VWD and VWF emphasizes the important role of VWF in medicine.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2006.01393.x","type":"journal-article","created":{"date-parts":[[2006,11,6]],"date-time":"2006-11-06T08:54:28Z","timestamp":1162803268000},"page":"563-572","source":"Crossref","is-referenced-by-count":23,"title":["The 80th anniversary of von Willebrand's disease: history, management and research"],"prefix":"10.1111","volume":"12","author":[{"given":"A. B.","family":"FEDERICI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"BERNTORP","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A.","family":"LEE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,11,6]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"87","article-title":"Hereditar pseudoemophili","volume":"68","author":"Von Willebrand EA","year":"1926","journal-title":"Fin Lakaresallsk Handl"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1959.tb00189.x"},{"key":"e_1_2_5_4_2","first-page":"724","article-title":"Measurement of platelet adhesiveness. A simple in vitro technique demonstrating an abnormality in VWD","volume":"62","author":"Salzman EW","year":"1963","journal-title":"J Lab Clin Med"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106480"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V41.5.687.687"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107465"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/newbio236104a0"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107469"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.71.5.1906"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108846"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112064"},{"key":"e_1_2_5_13_2","first-page":"296","article-title":"Decreased adhesion of platelet to subendothelium in von Willebrand disease","volume":"83","author":"Tschopp TP","year":"1974","journal-title":"J Lab Clin Med"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5822.317"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197407182910301"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/243293a0"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1977.tb00566.x"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109795"},{"key":"e_1_2_5_19_2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand disease","volume":"69","author":"Rodeghiero F","year":"1987","journal-title":"Blood"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(85)90060-1"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3874428"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/13.13.4699"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.19.6394"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.99.6.2123"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1053\/beha.2001.0132"},{"key":"e_1_2_5_26_2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/s-0037-1615884","article-title":"Molecular genetics of von Willebrand disease","volume":"82","author":"Ginsburg D","year":"1999","journal-title":"Thromb Haemost"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1053\/beha.2001.0137"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1053\/beha.2001.0138"},{"key":"e_1_2_5_29_2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease","volume":"71","author":"Sadler JE","year":"1994","journal-title":"Thromb Haemost"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-021105"},{"key":"e_1_2_5_31_2","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM\u20101VWD)","author":"Goodeve A","year":"2006","journal-title":"Blood"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614018"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01847.x"},{"key":"e_1_2_5_34_2","first-page":"415","article-title":"Purification of human and bovine fibrinogen","volume":"10","author":"Blomb\u00e4ck B","year":"1956","journal-title":"Arkiv Kemi"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1959.tb04010.x"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91197-7"},{"key":"e_1_2_5_37_2","first-page":"363","article-title":"The release of plasminogen activator and factor VIII by LVP, AVP, DDAVP, ATIII and OT in man","volume":"27","author":"Cash JD","year":"1974","journal-title":"Br J Haematol"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1657659"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mbc.0000167658.85143.49"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1989.tb02031.x"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.2.450"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1860.x"},{"key":"e_1_2_5_43_2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1055\/s-0038-1656323","article-title":"Recommended protocol for the study of the ex vivo biological effects of virus\u2010inactivated plasma concentrates in patients with von Willebrand disease","volume":"68","author":"Mannucci PM","year":"1992","journal-title":"Thromb Haemost"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2002.00672.x"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613992"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra040403"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613225"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mbc.0000167659.23262.18"},{"key":"e_1_2_5_49_2","doi-asserted-by":"crossref","first-page":"507a","DOI":"10.1182\/blood.V106.11.1782.1782","article-title":"Secondary long\u2010term prophylaxis in severe patients with von Willebrand disease: an Italian cohort study","volume":"106","author":"Federici AB","year":"2005","journal-title":"Blood"},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2006.01.016"},{"key":"e_1_2_5_51_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223"},{"key":"e_1_2_5_52_2","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ions","volume":"87","author":"Tsai HM","year":"1996","journal-title":"Blood"},{"key":"e_1_2_5_53_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119195"},{"key":"e_1_2_5_54_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503093321003"},{"key":"e_1_2_5_55_2","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1055\/s-0038-1656120","article-title":"Von Willebrand factor and factor VIII in acute cerebrovascular disease. Relationship to stroke subtype and mortality","volume":"77","author":"Catto AJ","year":"1997","journal-title":"Thromb Haemost"},{"key":"e_1_2_5_56_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04776.x"},{"key":"e_1_2_5_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01770.x"},{"key":"e_1_2_5_58_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-010322"},{"key":"e_1_2_5_59_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3605"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2006.01393.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2006.01393.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T02:38:25Z","timestamp":1697337505000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2006.01393.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["10.1111\/j.1365-2516.2006.01393.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2006.01393.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}